N@N

Tao Qiu Initiated (AMED) at Hold and Held Target at $128 on, Jun 29th, 2022

Tao Qiu of Stifel, Initiated "Amedisys, Inc." (AMED) at Hold and Held Target at $128 on, Jun 29th, 2022.

Tao has made no other calls on AMED in the last 4 months.

There are 8 other peers that have a rating on AMED. Out of the 8 peers that are also analyzing AMED, 3 agree with Tao's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022
• Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
• Andrew Mok of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $168 on, Tuesday, March 1st, 2022

These are the ratings of the 5 analyists that currently disagree with Tao

---

• David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
• Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022
• Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
• John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $180 on, Friday, April 29th, 2022
• A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $182 on, Friday, April 29th, 2022

Contributing Sources

---